Blood Culture pathway- Health economic analysis

Description

o create an economic model with real world data (RWD) to estimate the clinical and financial impacts of improving the pre-analytical phase of the blood culture practices in England. This will be used to inform future national guidance on specific diagnostics and care pathways for detecting infection and reducing Antimicrobial Resistance (AMR). Key objectives of this project To update the model with English RWD wherever possible. To validate the model inputs, assumptions and results with subject matter experts (SMEs). To update the report accordingly. To include additional levels of detail within the model, to more accurately capture the resource use, costs and benefits of optimising the blood culture pathway. To conduct additional analyses in the existing model, addressing other challenges. To design and develop a flexible interface for users inputting their own data and generate trust-specific outcomes and business cases. To develop the report into a manuscript. To submit the manuscript to a peer-reviewed journal (+/- submission to a pre-print journal) and provide peer-reviewed, referenceable evidence. Strategic rationale This aims to support the necessary changes in the blood culture pathway to save lives and improve patient outcomes from sepsis.

Key facts

Procedure

Below threshold - open competition

Lots

1

Contact

sharron giblin

sharron.giblin@nhs.net

Contract period

30 Oct 2026 → 31 Aug 2027

Value incl. VAT

£86k

Category

services

Awarded suppliers

• Imperial College healthcare NHS Trust · GB-PPON-PYMN-2374-JNRY · UKI32, GB